http://www.hc-sc.gc.ca/hpb/lcdc/biosafty/msds/msds12e.html
|
|||
|
[Material
Safety Data Sheets - Index] LABORATORY
CENTRE FOR DISEASE CONTROL MATERIAL
SAFETY DATA SHEET - INFECTIOUS SUBSTANCES SECTION I - INFECTIOUS
AGENT NAME: Bacillus anthracis SYNONYM OR CROSS REFERENCE: Anthrax, woolsorters' disease CHARACTERISTICS: Aerobic, large Gram positive rods occurring in
chains; non-motile; forms resistant spores SECTION II - HEALTH
HAZARD PATHOGENICITY: Cutaneous anthrax - skin lesion becoming papular,
then vesiculated and developing into a depressed eschar (5-20% case fatality
in untreated cases); inhalation anthrax - respiratory distress, fever and
shock with death shortly thereafter; intestinal anthrax - abdominal distress
followed by fever, septicemia and death (rare); oropharyngeal form described EPIDEMIOLOGY: Infrequent and sporadic in most industrial
countries; occupational hazard of workers who process hides, hair, wool, bone
and bone products; of laboratory workers and of veterinarians and
agricultural workers who handle infected animals; endemic in agricultural
regions where anthrax in animals is common (Africa, Asia and Middle East) HOST RANGE: Humans, cattle, sheep, goats, horses, pigs INFECTIOUS DOSE: 8,000 to 50,000 organisms by inhalation MODE OF TRANSMISSION: Infection of skin by contact with infected animal
tissues and possible by biting flies feeding on such animals, or by
contaminated hair, wool, hides or products made from them; inhalation anthrax
results from inhalation of spores in contaminated soil areas, dried or
processed skins and hides of infected animals; intestinal anthrax from
ingestion of contaminated undercooked meat INCUBATION PERIOD: Within 7 days of exposure, usually 2 to 5 COMMUNICABILITY: Transmission from person to person is very rare SECTION III -
DISSEMINATION RESERVOIR: Spores are resistant to adverse environmental
conditions and remain viable for years in soil, dried or processed hides ZOONOSIS: Yes - disease spreads among grazing animals through
contaminated soil and feed and among omnivorous and carnivorous animals
through contaminated meat, bone meal or other feed; vultures have been
reported to spread the organism from one area to another VECTORS: Infection of skin may possibly occur through biting
flies which had fed on infected animals SECTION IV - VIABILITY DRUG SUSCEPTIBILITY: Susceptible to penicillin (except for inhalation
anthrax in which the mortality remains high); ciprofloxacin, doxycycline,
tetracylines, erythromycin, chloramphenicol SUSCEPTIBILITY TO DISINFECTANTS: Spores are resistant to many disinfectants;
susceptible to 2% glutaraldehyde formaldehyde and 5% formalin (overnight soak
preferable) PHYSICAL INACTIVATION: Spores are highly resistant to drying, heat, and
sunlight; adequate sterilization requires direct exposure to 121°C for at
least 30 min SURVIVAL OUTSIDE HOST: Spores remain viable in soil, skins and hides of
infected animals and contaminated air and wool for decades; survival in milk
- 10 years; dried on filter paper - 41 years; dried on silk threads - up to
71 years; pond water - 2 years SECTION V - MEDICAL SURVEILLANCE: Monitor for suspicious skin lesions and other
symptoms; laboratory confirmation through direct microscopy, culture,
immunological techniques FIRST AID/TREATMENT: Prompt treatment with high-dose antibiotics IMMUNIZATION: Vaccine available through the Centers for Disease
Control and Prevention and is recommended for those workers with frequent
exposure to clinical specimens and cultures; vaccination of cattle or other
livestock may be justified in anthrax-endemic areas PROPHYLAXIS: Antibiotic treatment (oral ciprofloxacin or
doxycycline) SECTION VI - LABORATORY
HAZARDS LABORATORY-ACQUIRED INFECTIONS: 45 cases with 5 deaths occurring primarily in facilities
conducting anthrax research; 25 reported cases of cutaneous anthrax among
armed forces personnel SOURCES/SPECIMENS: Blood, skin lesion exudates, and rarely in urine and
faeces; hides, hair, wool, bone and bone products, and tissues from infected animals PRIMARY HAZARDS: Direct and indirect contact of skin with cultures
and contaminated laboratory surfaces; accidental parenteral inoculation;
exposure to infectious aerosols SPECIAL HAZARDS: Naturally and experimentally infected animals pose a
risk to laboratory and animal care personnel SECTION VII -
RECOMMENDED PRECAUTIONS CONTAINMENT REQUIREMENTS: Biosafety level 3 practices and facilities are
recommended for work with anthrax; Agriculture Canada may also require
special conditions for the use or importation of this agent PROTECTIVE CLOTHING: Use of adequate protective clothing (gloves, gowns
with tight wrists and ties in back) and facilities for washing and changing
clothes after work OTHER PRECAUTIONS: Care of skin abrasions and proper handling of
potentially contaminated articles is essential SECTION VIII - HANDLING
INFORMATION SPILLS: Allow aerosols to settle; wearing protective
clothing, gently cover spill with paper towels and apply suitable disinfectant
(glutaraldehyde, formalin), starting at the perimeter and working towards the
centre; allow sufficient contact time before clean up DISPOSAL: Incineration or steam sterilization of cultures and
infected materials; animals that have died from anthrax should be burned or
deeply buried and covered with lime STORAGE: In sealed containers that are appropriately
labelled and secured in a level 3 facility SECTION IX -
MISCELLANEOUS INFORMATION Date prepared: November 1999 Prepared by: Office of Biosafety, LCDC Although the information, opinions and
recommendations contained in this Material Safety Data Sheet are compiled
from sources believed to be reliable, we accept no responsibility for the
accuracy, sufficiency, or reliability or for any loss or injury resulting
from the use of the information. Newly discovered hazards are frequent and
this information may not be completely up to date. Copyright
© |
|
[LCDC] [HPB] [Contact] [Copyright/Disclaimer]
[Français] |
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.